Johanna Richter
Publications
- 2024
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C. & Kröger, N., 14.06.2024, In: MED-CAMBRIDGE. 5, 6, p. 550-558.e2Research output: SCORING: Contribution to journal › Case report › Research › peer-review
"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study
Volz, T., Sippel, A., Fischbach, F., Richter, J., Willison, A. G., Häußler, V. & Heesen, C., 01.05.2024, In: FRONT NEUROL. 15, p. 1384551Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation
Oechsler, S., Gagelmann, N., Wolschke, C., Janson, D., Badbaran, A., Klyuchnikov, E., Massoud, R., Rathje, K., Richter, J., Schäfersküpper, M., Niederwieser, C., Kunte, A., Heidenreich, S., Ayuk, F. & Kröger, N., 04.2024, In: BONE MARROW TRANSPL. 59, 4, p. 550-557 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life
Braun, B., Fischbach, F., Richter, J., Pfeffer, L. K., Fay, H., Reinhardt, S., Friese, M. A., Stellmann, J-P., Kröger, N. M., Heesen, C. & Häußler, V., 02.2024, In: MULT SCLER RELAT DIS. 82, p. 105414Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review